Medical Forum / Diseases and Disorders / Prostate Cancer / June 2005
Delaying radiation for prostate cancer does not affect outcome
|
|
Thread rating:  |
c palmer - 13 Jun 2005 09:55 GMT 13 Jun 2005
For men diagnosed with prostate cancer, there is no risk of recurrence if external beam radiation therapy (EBRT) is delayed by several months. A study published in the July 15, 2005 issue of CANCER (interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, finds delays of EBRT had no harmful impact on clinical outcome or biochemical marker levels in low-, intermediate- and high-risk patients. Prostate cancer is generally a slow-developing malignancy that affects older men. However, treatment is still important for survival and includes surgery and radiation. The forms of available radiotherapy include external beam radiation - 3D conformal radiation therapy (3DCRT), intensity modulated radiation therapy, or brachytherapy. Treatment delays of several months are quite common for men diagnosed with prostate cancer and can cause patients concern and anxiety. While radiation treatment delays in other cancers are associated with increased mortality, little is known about the effect of delaying treatment on the outcome of prostate cancer. Stephen F. Andrews, D.O. and colleagues from the Fox Chase Cancer Center in Philadelphia reviewed the data from almost 1500 men treated for locally confined prostate cancer to investigate the effect of 3DCRT delay on outcome. The investigators found that there was no difference in overall survival, disease specific survival, the incidence of distant metastases, and treatment failure for men who delayed 3DCRT more than nine months. Moreover, there was no difference in outcome for men with low-, intermediate-, and high-risk tumors who delayed treatment less than or more 3 months. For men with locally confined prostate cancer, "patients and physicians can use this information to alleviate concerns and anxiety regarding delaying treatment in order to make a well-informed treatment decision," conclude the authors. Article: "Does a Delay In External Beam Radiation Therapy after Tissue Diagnosis Affect Outcome for Men with Prostate Carcinoma?," Stephen F. Andrews, Eric M. Horwitz, Steven J. Feigenberg, Debra F. Eisenberg, Alexandra L. Hanlon, Robert G. Uzzo, Alan Pollack, CANCER; Published Online: June 13, 2005 (DOI: 10.1002/cncr.2184); Print Issue Date: July 15, 2005. John Wiley & Sons, Inc. http://www.interscience.wiley.com
knowledge is power - growing old is mandatory - growing wise is optional "Many more men die with prostate cancer than of it. Growing old is invariably fatal. Prostate cancer is only sometimes so." http://community.webtv.net/PALMER_ENT/doc
Alan Meyer - 13 Jun 2005 22:28 GMT > ... > The investigators found that there was no difference in overall [quoted text clipped - 9 lines] > well-informed treatment decision," conclude the authors. > ... Didn't we see this report a few months ago?
It makes no sense at all to me. If there is no patient for whom treatment cannot be delayed for 3 months (or 9 months in one of the formulations above) then, by induction, treatment is never necessary. Or to put it another way, treatment doesn't do any good.
After this total absurdity, we read the following:
> For men with locally confined prostate cancer, "patients and > physicians can use this information to alleviate concerns and > anxiety regarding delaying treatment in order to make a > well-informed treatment decision," conclude the authors. This frighteningly absurd conclusion is just the ticket to enable managed care administrators to kill their patients with inattention while maintaining a clear conscience.
Alan
I. P. Freely - 13 Jun 2005 23:35 GMT Clever, accurate, but deceptive insight. I think its fallacy -- there HAS to be one -- is that while the progosis changes in any given three/nine months are not statistically significant, the cumulative non-zero prognosis changes over several such periods IS often significant. But how many HMOs would point that out?
I.P.
"Alan Meyer" <ameyer2@yahoo.com> wrote >
> It makes no sense at all to me. If there is no patient for whom > treatment cannot be delayed for 3 months (or 9 months in one of [quoted text clipped - 14 lines] > > Alan Alan Meyer - 14 Jun 2005 03:49 GMT > Clever, accurate, but deceptive insight. > I think its fallacy -- there HAS to be one -- is that while the progosis changes in any [quoted text clipped - 3 lines] > > I.P. I don't see why there HAS to be a fallacy in my logic. There could very well be a fallacy in the study.
Here's an exact quote from the abstract online:
" There were no statistical differences in OS, CSS, DM, or FFBF among men whose EBRT began < 3, 3-6, 6-9, or > 9 months after diagnosis. This was also true at the median TTT of 3.1 months. A subgroup analysis was performed in which patients were stratified into low-, intermediate- and high-risk groups based on pretreatment PSA, Gleason score and AJCC T-stage. FFBF, and DM were calculated above and below the median TTT of 3.1 months. In this analysis, there was no statistically significant difference in FFBF or DM within the risk groups." (http://www3.interscience.wiley.com/cgi-bin/abstract/110514439/ABSTRACT)
OS = overall survival CSS = cause specific survival DM = distant metastasis FFBF = freedom from biochemical failure
Notice the "> 9 months" statement. It doesn't say how much greater.
They need to account for this - at least with a hypothesis. How many months _would_ be required to see a difference?
Consider this proposition: In any case of fatal prostate cancer, there is some point in time when a distant metastasis establishes itself and the cancer turns fatal. Before that point, the cancer may be cured by radiation. After that point it cannot.
From my layman's perspective, that proposition makes sense to me. If it's not, why not? If it is right, then won't that point, for at least _some_ patients, likely fall within the time period studied?
Here's another proposition: People are diagnosed at different stages of disease. One guy is diagnosed in plenty of time, another is not diagnosed until it's too late. Some patients are going to be diagnosed somewhere right between those two points in time - the point on one side of which it is not too late, and on the other side of which it is. Some guys are going to be diagnosed one month before that point.
I.P., your explanation of cumulative change requiring longer than 3 months - or actually longer than "> 9 months" seems to me possible, but not plausible. It would require that all changes in the development of the cancer be extraordinarily slow, and that the "point" in time when a metastasis establishes itself be longer than 3 or 9 months.
I have a friend who had a "normal" PSA test. He didn't know the number. Two years later he had another one that showed a PSA of 245. Two months after that it was 300. Clearly he's got metastatic cancer. He probably didn't have it two years before. It's easy to imagine there was a nine month period during which his cancer escaped the prostate and exploded into his body.
An alternative explanation might be that his cancer was metastatic but slow growing at the time of his normal PSA reading - in which case he was already beyond help. But whatever the actual case is, it seems to me that explanation is called for. Putting out data like this with no explanation for why it might be accurate seems to me to be really irresponsible.
I'm not saying that what Andrews et. al. reported is false. It might be true. If so there are many possible explanations - of which the possibility that radiation does no good - is clearly one of them. But I'd like to see the data checked, the math checked, the study repeated, and the objections raised above answered, before I'm ready to accept it.
Alan
> "Alan Meyer" <ameyer2@yahoo.com> wrote > >> It makes no sense at all to me. If there is no patient for whom [quoted text clipped - 15 lines] >> >> Alan I. P. Freely - 14 Jun 2005 06:24 GMT > "I. P. Freely" wrote >> Clever, accurate, but deceptive insight. >> I think its fallacy -- there HAS to be one -- is that while the progosis [quoted text clipped - 6 lines] > I don't see why there HAS to be a fallacy in my logic. There could > very well be a fallacy in the study. There MUST be a fallacy in any path that concludes
>>> If there is no patient for whom >>> treatment cannot be delayed for 3 months (or 9 months in one of >>> the formulations above) then, by induction, treatment is never >>> necessary. Or to put it another way, treatment doesn't do any >>> good. Isn't it more likely that "3 months' delay does no [statistically significant] harm" is truer than ""treatment does no good"? The former makes perfectly good sense in any slow process; the latter doesn't. Example: grass doesn't get noticeably taller in 24 hours, but it sure does in a week, and mowing it sure matters. It's a matter of the ratio of the sampling period to the growth rate.
> How > many months _would_ be required to see a difference? How high is up? PC can take years or many decades to kill.
> Consider this proposition: In any case of fatal prostate cancer, there is > some point in time when a distant metastasis establishes itself > and the cancer turns fatal. Before that point, the cancer may be > cured by radiation. After that point it cannot. There's a very broad gap in your proposition which can last for many years -- easily a decade -- in which cancer cells reside dormant and undetectable, waiting for the right conditions to "germinate". No mets, but untreatable because its existence and location are unknown. Then the cells' microenvironment changes in its favor and it's off to the races and down the tubes.
I.P.
Bill - 16 Jun 2005 15:14 GMT Here is the operative language: "For men with locally confined prostate cancer..." I assume they mean at the time of treatment. So if you use that limiting condition you could say that a delay of any length would not matter, assuming of course that the RT is effective in knocking out all the local PCa. As we all know, the monkey wrench in this analysis is that you can't be sure that you have local-only disease. The danger w/ this report is that doctors will delay a local-only patient and let him go metastatic by the time treatment begins. Personally, I don't think there is a lot of risk in men w/ early diagnoses of a few months. Now someone like me, w/ a first-time PSA of 30 - every day was taking a chance on metastasis.
Bill Denton RP 2/12/02 PSA .45 Memphis
Stephen Jordan - 16 Jun 2005 20:23 GMT On June 16, Bill Denton wrote, in pertinent part:
> Personally, I don't think there is a lot of risk in men w/ early > diagnoses of a few months. Now someone like me, w/ a first-time PSA > of 30 - every day was taking a chance on metastasis. Just a cautionary note: there's more to the markers to be monitored than just PSA.
The other two are DRE and especially Gleason score.
As I did, a man might have a relatively low PSA (5.7) and a high Gleason score (4+5=9 plus an initially undiscovered 4+4=8 one ). Gleason is a measure of the aggressiveness of the tumor(s).
Regards,
Steve J
"Always do right. This will gratify some people & astonish the rest." -- Mark Twain, "Advice to Youth"
c palmer - 14 Jun 2005 03:13 GMT Didn't we see this report a few months ago? It makes no sense at all to me. If there is no patient for whom treatment cannot be delayed for 3 months (or 9 months in one of the formulations above) then, by induction, treatment is never necessary. Or to put it another way, treatment doesn't do any good. Alan
=========hi alan - i was thinking there is one very similar to this or at least along the same lines. for that reason, i almost didn't post it, but thought i would, not so much to stir up anything, but to let people this is "suppose to be the latest news"
personally, i feel this is where figures don't lie, but liars do figure.
if one does have a slow growing pca, then a few months won't hurt at all. but, how can one know this to be a fact in each case that they are wanting to apply this article to? and what about the poor guy who was misdx'ed and now it has spread? what do you tell him? oops..... sorry about that.... well, have a nice life and don't blame me because i gave you bum advice.
i think that articles like this are dangerous because they are open ended.
but i post what i can find that is new because i want everyone to see what is out there and if that article gets ripped to sheds at the newsgroup, then we have done the lurkers a favor and gave them information that they may have not knowledge of.
~ curtis
knowledge is power - growing old is mandatory - growing wise is optional "Many more men die with prostate cancer than of it. Growing old is invariably fatal. Prostate cancer is only sometimes so." http://community.webtv.net/PALMER_ENT/doc
|
|
|